Anika Therapeutics Inc (ANIK) is a publicly traded Healthcare sector company. As of May 21, 2026, ANIK trades at $15.14 with a market cap of $198.92M and a P/E ratio of -19.92. ANIK moved +1.48% today. Year to date, ANIK is +59.87%; over the trailing twelve months it is +26.59%. Its 52-week range spans $7.87 to $25.65. Analyst consensus is buy with an average price target of $17.50. Rallies surfaces ANIK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Anika Therapeutics Inc (ANIK) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ANIK moved +1.48% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $15.14 |
| Market Cap | $198.92M |
| P/E Ratio | -19.92 |
| EPS | $-0.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $25.65 |
| 52-Week Low | $7.87 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $112.82M |
| Net Income | $-10.88M |
| Gross Margin | 56.56% |
2 analysts cover ANIK: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.50.